Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Mark Minden
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Anatomy
Chemicals & Drugs
Concepts & Ideas
Procedures
Physiology
Sign-in to see full Profile
Network (preview)
48
Messner, Hans
36
McCulloch, EA
23
Lipton, Jeffrey
23
Brandwein, Joseph
21
Schimmer, Aaron
18
Gupta, Vikas
17
Mak, Tak
13
Schuh, Andre
11
Kamel-Reid, Suzanne
11
Chun, Kathy
10
Hedley, David
9
Fyles, GM
9
Meharchand, Jacinta
8
Penn, Linda
8
Jamal, Nazir
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Mark Minden (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Alibhai Shabbir M H; Leach Marc; Minden Mark D; Brandwein Joseph
Outcomes and quality of care in acute myeloid leukemia over 40 years.
Cancer 2009;115(13):2903-11.
-
2009: Storring John M; Minden Mark D; Kao Susan; Gupta Vikas; Schuh Andre C; Schimmer Aaron D; Yee Karen W L; Kamel-Reid Suzanne; Chang Hong; Lipton Jeffrey H; Messner Hans A; Xu Wei; Brandwein Joseph M
Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen.
British journal of haematology 2009;146(1):76-85.
-
2009: Panju Abbas H; Danesh Ali; Minden Mark D; Kelvin David J; Alibhai Shabbir M H
Associations between quality of life, fatigue, and cytokine levels in patients aged 50+ with acute myeloid leukemia.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2009;17(5):539-46.
-
2009: Brandwein J M; Leber B F; Howson-Jan K; Schimmer A D; Schuh A C; Gupta V; Yee K W L; Wright J; Moore M; MacAlpine K; Minden M D;
A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(4):631-4.
-
2009: Alibhai Shabbir M H; Leach Marc; Gupta Vikas; Tomlinson George A; Brandwein Joseph M; Saiz Fernando Suarez; Minden Mark D
Quality of life beyond 6 months after diagnosis in older adults with acute myeloid leukemia.
Critical reviews in oncology/hematology 2009;69(2):168-74.
-
2008: Kao Susan Y; Xu Wei; Brandwein Joseph M; Lipton Jeffrey H; Messner Hans A; Minden Mark D; Schimmer Aaron D; Schuh Andre C; Yee Karen; Gupta Vikas
Outcomes of older patients (> or = 60 years) with acquired aplastic anaemia treated with immunosuppressive therapy.
British journal of haematology 2008;143(5):738-43.
-
2008: Wood Tabitha E; Dalili Shadi; Simpson Craig D; Hurren Rose; Mao Xinliang; Saiz Fernando Suarez; Gronda Marcela; Eberhard Yanina; Minden Mark D; Bilan Philip J; Klip Amira; Batey Robert A; Schimmer Aaron D
A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death.
Molecular cancer therapeutics 2008;7(11):3546-55.
-
2008: Kim Dong Hwan; Kumar Deepali; Messner Hans A; Minden Mark; Gupta Vikas; Kuruvilla John; Chae Yee Soo; Sohn Sang Kyun; Lipton Jeffrey H
Clinical efficacy of prophylactic strategy of long-term low-dose acyclovir for Varicella-Zoster virus infection after allogeneic peripheral blood stem cell transplantation.
Clinical transplantation 2008;22(6):770-9.
-
2008: Kersemans Veerle; Cornelissen Bart; Minden Mark D; Brandwein Joseph; Reilly Raymond M
Drug-resistant AML cells and primary AML specimens are killed by 111In-anti-CD33 monoclonal antibodies modified with nuclear localizing peptide sequences.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(9):1546-54.
-
2008: Han Youqi; Yang Lin; Suarez-Saiz Fernando; San-Marina Serban; Cui Jie; Minden Mark D
Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
Molecular cancer research : MCR 2008;6(8):1347-55.
-
2008: Siegal D; Xu W; Sutherland R; Kamel-Reid S; Kuruvilla J; Lipton J H; Minden M; Messner H; Gupta V
Graft-versus-host disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies.
Bone marrow transplantation 2008;42(1):51-6.
-
2008: Abdelhameed Arwa; Pond Gregory R; Mitsakakis Nicholas; Brandwein Joseph; Chun Kathy; Gupta Vikas; Kamel-Reid Suzanne; Lipton Jeffrey H; Minden Mark D; Schimmer Aaron; Schuh Andre; Yee Karen; Messner Hans A
Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
Cancer 2008;112(7):1513-21.
-
2008: Kim D H; Messner H; Minden M; Gupta V; Kuruvilla J; Wright J; Lipton J
Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders.
Transplant infectious disease : an official journal of the Transplantation Society 2008;10(2):90-8.
-
2008: San-Marina Serban; Han Youqi; Suarez Saiz Fernando; Trus Michael R; Minden Mark D
Lyl1 interacts with CREB1 and alters expression of CREB1 target genes.
Biochimica et biophysica acta 2008;1783(3):503-17.
-
2008: Brandwein Joseph M; Gupta Vikas; Schuh Andre C; Schimmer Aaron D; Yee Karen; Xu Wei; Messner Hans A; Lipton Jeffrey H; Minden Mark D
Predictors of response to reinduction chemotherapy for patients with acute myeloid leukemia who do not achieve complete remission with frontline induction chemotherapy.
American journal of hematology 2008;83(1):54-8.
-
2007: Bastianutto Carlo; Mian Asim; Symes Julie; Mocanu Joseph; Alajez Nehad; Sleep Gillian; Shi Wei; Keating Armand; Crump Michael; Gospodarowicz Mary; Medin Jeff; Minden Mark; Liu Fei-Fei
Local radiotherapy induces homing of hematopoietic stem cells to the irradiated bone marrow.
Cancer research 2007;67(21):10112-6.
-
2007: Kim Dong Hwan; Jamal Nazir; Saragosa Ronnie; Loach David; Wright Janice; Gupta Vikas; Kuruvilla John; Lipton Jeffrey H; Minden Mark; Messner Hans A
Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(10):1233-43.
-
2007: Alibhai Shabbir M H; Leach Marc; Kermalli Husnain; Gupta Vikas; Kowgier Matthew E; Tomlinson George A; Brandwein Joseph; Buckstein Rena; Minden Mark D
The impact of acute myeloid leukemia and its treatment on quality of life and functional status in older adults.
Critical reviews in oncology/hematology 2007;64(1):19-30.
-
2007: Zaretsky Y; Rifkind J; Lockwood G; Tsang R; Kiss T; Hasegawa W; Fyles G; Tejpar I; Loach D; Minden M; Messner H; Lipton J H
Long-term follow-up of allogeneic bone marrow transplantation for patients with chronic phase chronic myeloid leukemia prepared with a regimen consisting of cyclophosphamide, cytarabine and single-dose total body irradiation conditioning.
Bone marrow transplantation 2007;40(5):423-30.
-
2007: Disperati Patricia; Minden Mark D; Gupta Vikas; Schimmer Aaron D; Schuh Andre C; Yee Karen W L; Kamel-Reid Suzanne; Chang Hong; Xu Wei; Brandwein Joseph M
Acute promyelocytic leukemia in patients aged 70 years and over -- a single center experience of unselected patients.
Leukemia & lymphoma 2007;48(8):1654-8.
-
2007: Gupta V; Xu W; Keng C; Alibhai S M H; Brandwein J; Schimmer A; Schuh A; Yee K; Minden M D
The outcome of intensive induction therapy in patients >or=70 years with acute myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(6):1321-4.
-
2007: Yang L; Han Y; Suarez Saiz F; Minden M D
A tumor suppressor and oncogene: the WT1 story.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(5):868-76.
-
2007: Alibhai S M H; Leach M; Kowgier M E; Tomlinson G A; Brandwein J M; Minden M D
Fatigue in older adults with acute myeloid leukemia: predictors and associations with quality of life and functional status.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(4):845-8.
-
2007: Brandwein J M; Yang L; Schimmer A D; Schuh A C; Gupta V; Wells R A; Alibhai S M H; Xu W; Minden M D
A phase II study of temozolomide therapy for poor-risk patients aged >or=60 years with acute myeloid leukemia: low levels of MGMT predict for response.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(4):821-4.
-
2007: Corey Seth J; Minden Mark D; Barber Dwayne L; Kantarjian Hagop; Wang Jean C Y; Schimmer Aaron D
Myelodysplastic syndromes: the complexity of stem-cell diseases.
Nature reviews. Cancer 2007;7(2):118-29.
-
2007: Medeiros Bruno C; Minden Mark D; Schuh Andre C; Schimmer Aaron D; Yee Karen; Lipton Jeff H; Messner Hans A; Gupta Vikas; Chun Kathy; Xu Wei; Das Prabodh; Kamel-Reid Suzanne; Brandwein Joseph M
Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years).
Leukemia & lymphoma 2007;48(1):65-71.
-
2007: Han Youqi; San-Marina Serban; Yang Lin; Khoury Haytham; Minden Mark D
The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Breast cancer research : BCR 2007;9(4):R43.
-
2006: Aswald Jorg M; Wang Xing-Hua; Aswald Sandra; Lutynski Andrzej; Minden Mark D; Messner Hans A; Keating Armand
Flow cytometric assessment of autologous gammadelta T cells in patients with acute myeloid leukemia: potential effector cells for immunotherapy?
Cytometry. Part B, Clinical cytometry 2006;70(6):379-90.
-
2006: Chow Sue; Minden Mark D; Hedley David W
Constitutive phosphorylation of the S6 ribosomal protein via mTOR and ERK signaling in the peripheral blasts of acute leukemia patients.
Experimental hematology 2006;34(9):1183-91.
-
2006: Chen Paul; Wang Judy; Hope Kristin; Jin Liqing; Dick John; Cameron Ross; Brandwein Joseph; Minden Mark; Reilly Raymond M
Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(5):827-36.
-
2005: Gronda M; Brandwein J; Minden M D; Pond G R; Schuh A C; Wells R A; Messner H; Chun K; Schimmer A D
Assessment of the downstream portion of the mitochondrial pathway of caspase activation in patients with acute myeloid leukemia.
Apoptosis : an international journal on programmed cell death 2005;10(6):1285-94.
-
2005: Brandwein J M; Gupta V; Wells R A; Schuh A C; Schimmer A D; Lipton J H; Messner H A; Yi Q-L; Chun K; Kamel-Reid S; Minden M D
Treatment of elderly patients with acute lymphoblastic leukemia--evidence for a benefit of imatinib in BCR-ABL positive patients.
Leukemia research 2005;29(12):1381-6.
-
2005: Meng Y-S; Khoury H; Dick J E; Minden M D
Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(11):1941-7.
-
2005: Gupta Vikas; Daly Andrew; Lipton Jeffrey H; Hasegawa Wanda; Chun Kathy; Kamel-Reid Suzanne; Tsang Richard; Yi Qi-long; Minden Mark; Messner Hans; Kiss Thomas
Nonmyeloablative stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia in patients 60 years or older.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(10):764-72.
-
2005: Trus M R; Yang L; Suarez Saiz F; Bordeleau L; Jurisica I; Minden M D
The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(7):1161-8.
-
2005: Gupta Vikas; Chun Kathy; Yi Qi-Long; Minden Mark; Schuh Andre; Wells Richard; Brandwein Joseph
Disease biology rather than age is the most important determinant of survival of patients > or = 60 years with acute myeloid leukemia treated with uniform intensive therapy.
Cancer 2005;103(10):2082-90.
-
2005: Carter Bing Z; Gronda Marcela; Wang Zhiliang; Welsh Kate; Pinilla Clemencia; Andreeff Michael; Schober Wendy D; Nefzi Adel; Pond Gregory R; Mawji Imtiaz A; Houghten Richard A; Ostresh John; Brandwein Joseph; Minden Mark D; Schuh Andre C; Wells Richard A; Messner Hans; Chun Kathy; Reed John C; Schimmer Aaron D
Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells.
Blood 2005;105(10):4043-50.
-
2005: Gupta Vikas; Yi Qi-long; Brandwein Joseph; Lipton Jeffrey H; Messner Hans A; Schuh Andre C; Wells Richard A; Minden Mark D
Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).
Leukemia research 2005;29(1):113-4.
-
2004: Tinmouth Alan; Tannock Ian F; Crump Michael; Tomlinson George; Brandwein Joseph; Minden Mark; Sutton David
Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design.
Transfusion 2004;44(12):1711-9.
-
2004: Wu Jianghong; Wong W Wei-Lynn; Khosravi Fereshteh; Minden Mark D; Penn Linda Z
Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis.
Cancer research 2004;64(18):6461-8.
-
2004: Han Youqi; San-Marina Serban; Liu Jian; Minden Mark D
Transcriptional activation of c-myc proto-oncogene by WT1 protein.
Oncogene 2004;23(41):6933-41.
-
2004: Dorrell Craig; Takenaka Katsuto; Minden Mark D; Hawley Robert G; Dick John E
Hematopoietic cell fate and the initiation of leukemic properties in primitive primary human cells are influenced by Ras activity and farnesyltransferase inhibition.
Molecular and cellular biology 2004;24(16):6993-7002.
-
2004: Shago Mary; Bouman Derek; Kamel-Reid Suzanne; Minden Mark; Chun Kathy
Cryptic insertion of MLL gene into 9p22 leads to MLL-MLLT3 (AF9) fusion in a case of acute myelogenous leukemia.
Genes, chromosomes & cancer 2004;40(4):349-54.
-
2004: Gupta Vikas; Yib Qi-Long; Brandwein Joseph; Chun Kathy; Lipton Jeffrey H; Messner Hans; Schuh Andre C; Wells Richard A; Minden Mark D; Kamel-Reidc Suzanne
Clinico-biological features and prognostic significance of PML/RARalpha isoforms in adult patients with acute promyelocytic leukemia treated with all trans retinoic acid (ATRA) and chemotherapy.
Leukemia & lymphoma 2004;45(3):469-80.
-
2004: Gupta V; Yi Q-L; Brandwein J; Minden M D; Schuh A C; Wells R A; Chun K; Kamel-Reid S; Tsang R; Daly A; Kiss T; Lipton J H; Messner H A
The role of allogeneic bone marrow transplantation in adult patients below the age of 55 years with acute lymphoblastic leukemia in first complete remission: a donor vs no donor comparison.
Bone marrow transplantation 2004;33(4):397-404.
-
2003: Suh W-S; Kim Y S; Schimmer A D; Kitada S; Minden M; Andreeff M; Suh N; Sporn M; Reed J C
Synthetic triterpenoids activate a pathway for apoptosis in AML cells involving downregulation of FLIP and sensitization to TRAIL.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(11):2122-9.
-
2003: Gupta Vikas; Minden Mark D; Yi Qi-Long; Brandwein Joseph; Chun Kathy
Prognostic significance of trisomy 4 as the sole cytogenetic abnormality in acute myeloid leukemia.
Leukemia research 2003;27(11):983-91.
-
2003: Yee Karen W L; Moore Susan J; Midmer Michael; Zanke Brent W; Tong Frances; Hedley David; Minden Mark D
NKIAMRE, a novel conserved CDC2-related kinase with features of both mitogen-activated protein kinases and cyclin-dependent kinases.
Biochemical and biophysical research communications 2003;308(4):784-92.
-
2003: Kolomietz E; Marrano P; Yee K; Thai B; Braude I; Kolomietz A; Chun K; Minkin S; Kamel-Reid S; Minden M; Squire J A
Quantitative PCR identifies a minimal deleted region of 120 kb extending from the Philadelphia chromosome ABL translocation breakpoint in chronic myeloid leukemia with poor outcome.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(7):1313-23.
-
2003: Gupta V; Kamel-Reid S; Minden M D; Lipton J H; Brandwein J; Messner H A
Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemias.
Hematology (Amsterdam, Netherlands) 2003;8(3):139-43.
-
2003: Schimmer Aaron D; Munk-Pedersen Irene; Minden Mark D; Reed John C
Bcl-2 and apoptosis in chronic lymphocytic leukemia.
Current treatment options in oncology 2003;4(3):211-8.
-
2003: Trus Michael R; Bordeleau Louise; Pihl Carin; McGeer Allison; Prevost Jay; Minden Mark D; Brown Christopher B
Clinical manifestations associated with the aberrant expression of the soluble granulocyte-macrophage colony-stimulating factor receptor in patients presenting with haematological malignancies.
British journal of haematology 2003;121(1):86-93.
-
2003: Al-Zahrani H; Gupta V; Minden M D; Messner H A; Lipton J H
Vascular events associated with alpha interferon therapy.
Leukemia & lymphoma 2003;44(3):471-5.
-
2003: Schimmer Aaron D; Pedersen Irene Munk; Kitada Shinichi; Eksioglu-Demiralp Emel; Minden Mark D; Pinto Ryan; Mah Ken; Andreeff Michael; Kim Youngsoo; Suh Won Suk; Reed John C
Functional blocks in caspase activation pathways are common in leukemia and predict patient response to induction chemotherapy.
Cancer research 2003;63(6):1242-8.
-
2002: Wang Kan-Kan; Liu Ni; Radulovich Nikolina; Wigle Dennis A; Johnston Michael R; Shepherd Frances A; Minden Mark D; Tsao Ming-Sound
Novel candidate tumor marker genes for lung adenocarcinoma.
Oncogene 2002;21(49):7598-604.
-
2002: Kiss T L; Abdolell M; Jamal N; Minden M D; Lipton J H; Messner H A
Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(9):2334-43.
-
2002: Wong W W L; Dimitroulakos J; Minden M D; Penn L Z
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(4):508-19.
-
2002: Mehra Sukvarsha; Messner Hans; Minden Mark; Chaganti R S K
Molecular cytogenetic characterization of non-Hodgkin lymphoma cell lines.
Genes, chromosomes & cancer 2002;33(3):225-34.
-
2001: Schimmer A D; Hedley D W; Penn L Z; Minden M D
Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view.
Blood 2001;98(13):3541-53.
-
2001: Xia Z; Tan M M; Wong W W; Dimitroulakos J; Minden M D; Penn L Z
Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(9):1398-407.
-
2001: Schimmer A D; Hedley D W; Pham N A; Chow S; Minden M D
BAD induces apoptosis in cells over-expressing Bcl-2 or Bcl-xL without loss of mitochondrial membrane potential.
Leukemia & lymphoma 2001;42(3):429-43.
-
2001: Schimmer A D; Hedley D W; Chow S; Pham N A; Chakrabartty A; Bouchard D; Mak T W; Trus M R; Minden M D
The BH3 domain of BAD fused to the Antennapedia peptide induces apoptosis via its alpha helical structure and independent of Bcl-2.
Cell death and differentiation 2001;8(7):725-33.
-
2001: Wong W W; Tan M M; Xia Z; Dimitroulakos J; Minden M D; Penn L Z
Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(7):2067-75.
-
2001: Minden M D; Dimitroulakos J; Nohynek D; Penn L Z
Lovastatin induced control of blast cell growth in an elderly patient with acute myeloblastic leukemia.
Leukemia & lymphoma 2001;40(5-6):659-62.
-
2000: Dimitroulakos J; Thai S; Wasfy G H; Hedley D W; Minden M D; Penn L Z
Lovastatin induces a pronounced differentiation response in acute myeloid leukemias.
Leukemia & lymphoma 2000;40(1-2):167-78.
-
2000: Lakosha H; Simpson R; Patterson B; Minden M; Payne D; Lipton J H
Acute lymphocytic blast crisis as an ocular manifestation of chronic granulocytic leukemia.
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2000;35(6):336-9.
-
2000: Hu Z B; Minden M D; McCulloch E A; Stahl J
Regulation of drug sensitivity by ribosomal protein S3a.
Blood 2000;95(3):1047-55.
-
2000: Schimmer A D; Minden M D; Keating A
Osteoporosis after blood and marrow transplantation: clinical aspects.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(2A):175-81.
-
1999: Crump M; Lipton J; Hedley D; Sutton D; Shepherd F; Minden M; Stewart K; Beare S; Eisenhauer E
Phase I trial of sequential topotecan followed by etoposide in adults with myeloid leukemia: a National Cancer Institute of Canada Clinical Trials Group Study.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(3):343-7.
-
1999: Dimitroulakos J; Nohynek D; Backway K L; Hedley D W; Yeger H; Freedman M H; Minden M D; Penn L Z
Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach.
Blood 1999;93(4):1308-18.
-
1999: Messner H A; Curtis J E; Lipton J L; Meharchand J M; Minden M D; Panzarella A
Three decades of allogeneic bone marrow transplants at the Princess Margaret Hospital.
Clinical transplants 1999;():289-94.
-
1998: Hedley D W; McCulloch E A; Minden M D; Chow S; Curtis J
Antileukemic action of buthionine sulfoximine: evidence for an intrinsic death mechanism based on oxidative stress.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(10):1545-52.
-
1998: Hu Z B; Minden M D; McCulloch E A
Phosphorylation of BCL-2 after exposure of human leukemic cells to retinoic acid.
Blood 1998;92(5):1768-75.
-
1998: Wang J C; Lapidot T; Cashman J D; Doedens M; Addy L; Sutherland D R; Nayar R; Laraya P; Minden M; Keating A; Eaves A C; Eaves C J; Dick J E
High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase.
Blood 1998;91(7):2406-14.
-
1997: Dong W F; Heng H H; Lowsky R; Xu Y; DeCoteau J F; Shi X M; Tsui L C; Minden M D
Cloning, expression, and chromosomal localization to 11p12-13 of a human LIM/HOMEOBOX gene, hLim-1.
DNA and cell biology 1997;16(6):671-8.
-
1997: Sutherland H J; Fyles G M; Adams G; Hao Y; Lipton J H; Minden M D; Meharchand J M; Atkins H; Tejpar I; Messner H A
Quality of life following bone marrow transplantation: a comparison of patient reports with population norms.
Bone marrow transplantation 1997;19(11):1129-36.
-
1997: Wu H K; Minden M D
Transcriptional activation of human LIM-HOX gene hLH-2 in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl.
Biochemical and biophysical research communications 1997;234(3):742-7.
-
1997: Wu H K; Minden M D
Transcriptional activation of human LIM-HOX gene, hLH-2, in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl.
Biochemical and biophysical research communications 1997;233(3):806-12.
-
1997: Lowsky R; DeCoteau J F; Reitmair A H; Ichinohasama R; Dong W F; Xu Y; Mak T W; Kadin M E; Minden M D
Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL).
Blood 1997;89(7):2276-82.
-
1997: Wu H K; Weksberg R; Minden M D; Squire J A
Loss of imprinting of human insulin-like growth factor II gene, IGF2, in acute myeloid leukemia.
Biochemical and biophysical research communications 1997;231(2):466-72.
-
1997: Hedley D W; Xie S X; Minden M D; Choi C H; Chen H; Ling V
A novel energy dependent mechanism reducing daunorubicin accumulation in acute myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11(1):48-53.
-
1996: Hu Z B; Minden M D; McCulloch E A
Regulation of the synthesis of bcl-2 protein by growth factors.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(12):1925-9.
-
1996: Curtis J E; Minkin S; Minden M D; McCulloch E A
A role for paclitaxel in the combination chemotherapy of acute myeloblastic leukaemia: preclinical cell culture studies.
British journal of haematology 1996;95(2):354-63.
-
1996: LaCasse E C; Saleh M T; Patterson B; Minden M D; Gariépy J
Shiga-like toxin purges human lymphoma from bone marrow of severe combined immunodeficient mice.
Blood 1996;88(5):1561-7.
-
1996: Fu L; Minden M D; Benchimol S
Translational regulation of human p53 gene expression.
The EMBO journal 1996;15(16):4392-401.
-
1996: Minden M; Imrie K; Keating A
Acute leukemia in adults.
Current opinion in hematology 1996;3(4):259-65.
-
1996: Lipton J H; Messner H A; Curtis J E; Atkins H L; Minden M D
Intensive remission induction therapy for chronic myeloid leukemia in blast phase with a goal of post-remission bone marrow transplant--a pilot study.
European journal of haematology 1996;57(1):42-5.
-
1996: Dong W F; Billia F; Atkins H L; Iscove N N; Minden M D
Expression of rhombotin 2 in normal and leukaemic haemopoietic cells.
British journal of haematology 1996;93(2):280-6.
-
1996: Lowsky R; Fyles G; Minden M; Lipton J; Meharchand J; Tejpar I; Zipursky A; Messner H
Detection of donor cell derived acute myelogenous leukaemia in a patient transplanted for chronic myelogenous leukaemia using fluorescence in situ hybridization.
British journal of haematology 1996;93(1):163-5.
-
1996: Wu H K; Heng H H; Siderovski D P; Dong W F; Okuno Y; Shi X M; Tsui L C; Minden M D
Identification of a human LIM-Hox gene, hLH-2, aberrantly expressed in chronic myelogenous leukaemia and located on 9q33-34.1.
Oncogene 1996;12(6):1205-12.
-
1996: Hu Z B; Minden M D; McCulloch E A
Post-transcriptional regulation of bcl-2 in acute myeloblastic leukemia: significance for response to chemotherapy.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(3):410-6.
-
1996: Sirard C; Lapidot T; Vormoor J; Cashman J D; Doedens M; Murdoch B; Jamal N; Messner H; Addey L; Minden M; Laraya P; Keating A; Eaves A; Lansdorp P M; Eaves C J; Dick J E
Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis.
Blood 1996;87(4):1539-48.
-
1996: McCulloch E A; Minkin S; Curtis J E; Minden M D
Response of the blast stem cells of acute myeloblastic leukemia to G-CSF, GM-CSF, or the ligand for C-KIT, alone or in combination.
Hematopathology and molecular hematology 1996;10(3):111-22.
-
1995: Dong W F; Xu Y; Hu Q L; Munroe D; Minowada J; Housman D E; Minden M D
Molecular characterization of a chromosome translocation breakpoint t(11;14)(p13;q11) from the cell line KOPT-K1.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(11):1812-7.
-
1995: Hu Z B; Minden M D; McCulloch E A
Direct evidence for the participation of bcl-2 in the regulation by retinoic acid of the Ara-C sensitivity of leukemic stem cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(10):1667-73.
-
1995: Chang H; Blondal J A; Benchimol S; Minden M D; Messner H A
p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines.
Leukemia & lymphoma 1995;19(1-2):165-71.
-
1995: Wu H K; Heng H H; Shi X M; Forsdyke D R; Tsui L C; Mak T W; Minden M D; Siderovski D P
Differential expression of a basic helix-loop-helix phosphoprotein gene, G0S8, in acute leukemia and localization to human chromosome 1q31.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(8):1291-8.
-
1995: Minden M
Growth factor requirements for normal and leukemic cells.
Seminars in hematology 1995;32(3):162-82.
-
1995: Hu Q; Trevisan M; Xu Y; Dong W; Berger S A; Lyman S D; Minden M D
c-KIT expression enhances the leukemogenic potential of 32D cells.
The Journal of clinical investigation 1995;95(6):2530-8.
-
1995: Hu Z B; Yang G S; Li M; Miyamoto N; Minden M D; McCulloch E A
Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(5):789-98.
-
1995: Curtis J E; Minden M D; Minkin S; McCulloch E A
Sensitivities of AML blast stem cells to idarubicin and daunorubicin: a comparison with normal hematopoietic progenitors.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(3):396-404.
-
1994: Yang G S; Minden M D; McCulloch E A
Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(12):2065-75.
-
1994: Yang G S; Wang C; Minden M D; McCulloch E A
Fluorescence-labeling of nicks in DNA from leukemic blast cells as a measure of damage following cytosine arabinoside. Application to the study of regulated drug sensitivity.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(12):2052-9.
-
1994: Lowsky R; Archer G L; Fyles G; Minden M; Curtis J; Messner H; Atkins H; Patterson B; Willey B M; McGeer A
Brief report: diagnosis of Whipple's disease by molecular analysis of peripheral blood.
The New England journal of medicine 1994;331(20):1343-6.
-
1994: Lowsky R; Lipton J; Fyles G; Minden M; Meharchand J; Tejpar I; Atkins H; Sutcliffe S; Messner H
Secondary malignancies after bone marrow transplantation in adults.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(10):2187-92.
-
1994: Xu W M; Piao X H; Addy L; Jamal M; Minden M D; Messner H A
Minimal residual disease in bone marrow transplant recipients with chronic myeloid leukemia.
Bone marrow transplantation 1994;14(2):299-306.
-
1994: Kiss T L; Lipton J H; Bergsagel D E; Meharchand J M; Jamal N; Minden M D; Messner H A
Determination of IL6, IL1, and IL4 in the plasma of patients with multiple myeloma.
Leukemia & lymphoma 1994;14(3-4):335-40.
-
1994: Zanke B; Squire J; Griesser H; Henry M; Suzuki H; Patterson B; Minden M; Mak T W
A hematopoietic protein tyrosine phosphatase (HePTP) gene that is amplified and overexpressed in myeloid malignancies maps to chromosome 1q32.1.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(2):236-44.
-
1994: Zhu W M; Dong W F; Minden M
Alternate splicing creates two forms of the human kit protein.
Leukemia & lymphoma 1994;12(5-6):441-7.
-
1994: Lapidot T; Sirard C; Vormoor J; Murdoch B; Hoang T; Caceres-Cortes J; Minden M; Paterson B; Caligiuri M A; Dick J E
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.
Nature 1994;367(6464):645-8.
-
1994: Chang H; Benchimol S; Minden M D; Messner H A
Alterations of p53 and c-myc in the clonal evolution of malignant lymphoma.
Blood 1994;83(2):452-9.
-
1994: Piao X; Curtis J E; Minkin S; Minden M D; Bernstein A
Expression of the Kit and KitA receptor isoforms in human acute myelogenous leukemia.
Blood 1994;83(2):476-81.
-
1993: Yang G S; Minden M D; McCulloch E A
Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(7):1012-9.
-
1993: Tohda S; Yang G S; Ashman L K; McCulloch E A; Minden M D
Relationship between c-Kit expression and proliferation in acute myeloblastic leukemia cell lines.
Journal of cellular physiology 1993;154(2):410-8.
-
1993: McCulloch E A; Minden M D
The cell surface receptor encoded by the proto-oncogene KIT and its ligand.
Cancer treatment and research 1993;64():45-77.
-
1992: Curtis J E; Messner H A; Minden M D; Lipton J H; Lockwood G A; Tritchler D L; McCulloch E A
High-dose cytosine arabinoside remission induction for acute myelogenous leukemia: comparison of two regimens of remission maintenance.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6(11):1192-8.
-
1992: Chang H; Jamal N; Wang X H; Minden M D; Messner H A
Constitutive production of the interleukins IL-5 and IL-6 by the lymphoma cell line OCI-Ly 17 derived from a patient with malignant lymphoma and hypereosinophilia.
Leukemia & lymphoma 1992;8(1-2):97-107.
-
1992: Chang H; Leeder S; Cook V A; Patterson B; Dosch M; Minden M D; Messner H A
Growth of human lymphoma cells in SCID mice.
Leukemia & lymphoma 1992;8(1-2):129-36.
-
1992: Tohda S; Curtis J E; McCulloch E A; Minden M D
Comparison of the effects of all-trans and cis-retinoic acid on the blast stem cells of acute myeloblastic leukemia in culture.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6(7):656-61.
-
1992: Crump M; Larratt L M; Maki E; Curtis J E; Minden M D; Meharchand J M; Lipton J H; Messner H A
Treatment of adults with severe aplastic anemia: primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation.
The American journal of medicine 1992;92(6):596-602.
-
1992: Chang H; Messner H A; Wang X H; Yee C; Addy L; Meharchand J; Minden M D
A human lymphoma cell line with multiple immunoglobulin rearrangements.
The Journal of clinical investigation 1992;89(3):1014-20.
-
1992: Zanke B; Suzuki H; Kishihara K; Mizzen L; Minden M; Pawson A; Mak T W
Cloning and expression of an inducible lymphoid-specific, protein tyrosine phosphatase (HePTPase).
European journal of immunology 1992;22(1):235-9.
-
1991: Fyles G M; Messner H A; Lockwood G; Curtis J E; Rider W; Minden M D; Meharchand J M; Lipton J; Tritchler D; Van Dyk J
Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate.
Bone marrow transplantation 1991;8(6):453-63.
-
1991: Tohda S; Minden M D; McCulloch E A
Interactions between retinoic acid and colony-stimulating factors affecting the blast cells of acute myeloblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5(11):951-7.
-
1991: Hitzler J K; Martinez-Valdez H; Bergsagel D B; Minden M D; Messner H A
Role of interleukin-6 in the proliferation of human multiple myeloma cell lines OCI-My 1 to 7 established from patients with advanced stage of the disease.
Blood 1991;78(8):1996-2004.
-
1991: Martinez-Valdez H; Takihara Y; Champagne E; Minden M; Mak T W; Cohen A
Differential regulation of gamma and delta T cell antigen receptor gene expression by phorbol esters and Ca2+ ionophores in the acute lymphocyte leukemia DND41 cell line.
European journal of immunology 1991;21(10):2625-8.
-
1991: Yee C S; Messner H A; Minden M D
Regulation of interleukin-6 expression in the lymphoma cell line OCI-LY3.
Journal of cellular physiology 1991;148(3):426-9.
-
1991: Koistinen P; Wang C; Yang G S; Wang Y F; Williams D E; Lyman S D; Minden M D; McCulloch E A
OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5(8):704-11.
-
1991: Yang G S; Wang C; Minkin S; Minden M D; McCulloch E A
Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside.
Journal of cellular physiology 1991;148(1):60-7.
-
1991: Wang C; Koistinen P; Yang G S; Williams D E; Lyman S D; Minden M D; McCulloch E A
Mast cell growth factor, a ligand for the receptor encoded by c-kit, affects the growth in culture of the blast cells of acute myeloblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5(6):493-9.
-
1991: Slingerland J M; Minden M D; Benchimol S
Mutation of the p53 gene in human acute myelogenous leukemia.
Blood 1991;77(7):1500-7.
-
1990: Chien J; Chan C K; Chamberlain D; Patterson B; Fyles G; Minden M; Meharchand J; Messner H
Cytomegalovirus pneumonia in allogeneic bone marrow transplantation. An immunopathologic process?
Chest 1990;98(4):1034-7.
-
1990: Lu M; Dubé I; Raimondi S; Carroll A; Zhao Y; Minden M; Sutherland P
Molecular characterization of the t(10;14) translocation breakpoints in T-cell acute lymphoblastic leukemia: further evidence for illegitimate physiological recombination.
Genes, chromosomes & cancer 1990;2(3):217-22.
-
1990: Wang C; Lishner M; Minden M D; McCulloch E A
The effects of leukemia inhibitory factor (LIF) on the blast stem cells of acute myeloblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1990;4(8):548-52.
-
1990: Lishner M; Patterson B; Kandel R; Fyles G; Curtis J E; Meharchand J; Minden M D; Messner H A
Cutaneous and mucosal neoplasms in bone marrow transplant recipients.
Cancer 1990;65(3):473-6.
-
1990: Rose E A; Glaser T; Jones C; Smith C L; Lewis W H; Call K M; Minden M; Champagne E; Bonetta L; Yeger H
Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor gene.
Cell 1990;60(3):495-508.
-
1990: McCulloch E A; Minden M D; Curtis J E
The influence of growth regulation on treatment strategy for acute myeloblastic leukaemia.
Cancer surveys 1990;9(1):169-98.
-
1990: Gorska-Flipot I; Norman C; Addy L; Minden M
Molecular pathology of chronic myelogenous leukemia.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1990;11 Suppl 1():25-43.
-
1989: Yumura-Yagi K; Hara J; Terada N; Ishihara S; Tawa A; Takihara Y; Champagne E; Minden M D; Mak T W; Kawa-Ha K
Analysis of molecular events in leukemic cells arrested at an early stage of T-cell differentiation.
Blood 1989;74(6):2103-11.
-
1989: Wang C; Curtis J E; Geissler E N; McCulloch E A; Minden M D
The expression of the proto-oncogene C-kit in the blast cells of acute myeloblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(10):699-702.
-
1989: Yee C; Biondi A; Wang X H; Iscove N N; de Sousa J; Aarden L A; Wong G G; Clark S C; Messner H A; Minden M D
A possible autocrine role for interleukin-6 in two lymphoma cell lines.
Blood 1989;74(2):798-804.
-
1989: Tweeddale M; Jamal N; Nguyen A; Wang X H; Minden M D; Messner H A
Production of growth factors by malignant lymphoma cell lines.
Blood 1989;74(2):572-8.
-
1989: Champagne E; Takihara Y; Sagman U; de Sousa J; Burrow S; Lewis W H; Mak T W; Minden M D
The T-cell receptor delta chain locus is disrupted in the T-ALL associated t(11;14)(p13;q11) translocation.
Blood 1989;73(6):1672-6.
-
1989: Wang C; Curtis J E; Minden M D; McCulloch E A
Expression of a retinoic acid receptor gene in myeloid leukemia cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(4):264-9.
-
1989: Takihara Y; Champagne E; Ciccone E; Moretta L; Minden M; Mak T W
Organization and orientation of a human T cell receptor delta chain V gene segment that suggests an inversion mechanism is utilized in its rearrangement.
European journal of immunology 1989;19(3):571-4.
-
1989: Hara J; Benedict S H; Champagne E; Mak T W; Minden M; Gelfand E W
Relationship between rearrangement and transcription of the T-cell receptor alpha, beta, and gamma genes in B-precursor acute lymphoblastic leukemia.
Blood 1989;73(2):500-8.
-
1988: McCulloch E A; Kelleher C A; Miyauchi J; Wang C; Cheng G Y; Minden M D; Curtis J E
Heterogeneity in acute myeloblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1988;2(12 Suppl):38S-49S.
-
1988: Hara J; Benedict S H; Champagne E; Takihara Y; Mak T W; Minden M; Gelfand E W
T cell receptor delta gene rearrangements in acute lymphoblastic leukemia.
The Journal of clinical investigation 1988;82(6):1974-82.
-
1988: Champagne E; Takihara Y; Sagman U; Burrow S; de Sousa J; Mak T W; Minden M D
The isolation of the human delta chain gene and its expression in normal T cells and T cell leukemias.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1988;2(11):717-21.
-
1988: Takihara Y; Tkachuk D; Michalopoulos E; Champagne E; Reimann J; Minden M; Mak T W
Sequence and organization of the diversity, joining, and constant region genes of the human T-cell delta-chain locus.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(16):6097-101.
-
1988: Wandl U; Hoang T; Minden M; Messner H A
Segregation of precursors with high proliferative potential from their differentiated progeny in a myeloma cell line.
Journal of cellular physiology 1988;136(2):384-8.
-
1988: Tkachuk D C; Griesser H; Takihara Y; Champagne E; Minden M; Feller A C; Lennert K; Mak T W
Rearrangement of T-cell delta locus in lymphoproliferative disorders.
Blood 1988;72(1):353-7.
-
1988: Champagne E; Sagman U; Biondi A; Lewis W H; Mak T W; Minden M D
Structure and rearrangement of the T cell receptor J alpha locus in T cells and leukemic T cell lines.
European journal of immunology 1988;18(7):1033-8.
-
1988: Miyauchi J; Kelleher C A; Wong G G; Yang Y C; Clark S C; Minkin S; Minden M D; McCulloch E A
The effects of combinations of the recombinant growth factors GM-CSF, G-CSF, IL-3, and CSF-1 on leukemic blast cells in suspension culture.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1988;2(6):382-7.
-
1988: Miyauchi J; Wang C; Kelleher C A; Wong G G; Clark S C; Minden M D; McCulloch E A
The effects of recombinant CSF-1 on the blast cells of acute myeloblastic leukemia in suspension culture.
Journal of cellular physiology 1988;135(1):55-62.
-
1988: Wang C; Kelleher C A; Cheng G Y; Miyauchi J; Wong G G; Clark S C; Minden M D; McCulloch E A
Expression of the CSF-1 gene in the blast cells of acute myeloblastic leukemia: association with reduced growth capacity.
Journal of cellular physiology 1988;135(1):133-8.
-
1988: Hara J; Benedict S H; Champagne E; Mak T W; Minden M; Gelfand E W
Comparison of T cell receptor alpha, beta, and gamma gene rearrangement and expression in T cell acute lymphoblastic leukemia.
The Journal of clinical investigation 1988;81(4):989-96.
-
1988: Griesser H; Champagne E; Tkachuk D; Takihara Y; Lalande M; Baillie E; Minden M; Mak T W
The human T cell receptor alpha-delta locus: a physical map of the variable, joining and constant region genes.
European journal of immunology 1988;18(4):641-4.
-
1988: Kelleher C A; Wong G G; Clark S C; Schendel P F; Minden M D; McCulloch E A
Binding of iodinated recombinant human GM-CSF to the blast cells of acute myeloblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1988;2(4):211-5.
-
1988: Takihara Y; Champagne E; Griesser H; Kimura N; Tkachuk D; Reimann J; Okada A; Alt F W; Chess L; Minden M
Sequence and organization of the human T cell delta chain gene.
European journal of immunology 1988;18(2):283-7.
-
1988: Cheng G Y; Kelleher C A; Miyauchi J; Wang C; Wong G; Clark S C; McCulloch E A; Minden M D
Structure and expression of genes of GM-CSF and G-CSF in blast cells from patients with acute myeloblastic leukemia.
Blood 1988;71(1):204-8.
-
1988: Henkelman R M; Messner H; Poon P Y; Hinks R S; Stewart C; Curtis J; Minden M; Baker M
Magnetic resonance imaging for monitoring relapse of acute myeloid leukemia.
Leukemia research 1988;12(10):811-6.
-
1988: McCulloch E A; Minden M D; Miyauchi J; Kelleher C A; Wang C
Stem cell renewal and differentiation in acute myeloblastic leukaemia.
Journal of cell science. Supplement 1988;10():267-81.
-
1987: Urbanski S J; Kossakowska A E; Curtis J; Chan C K; Hutcheon M A; Hyland R H; Messner H; Minden M; Sculier J P
Idiopathic small airways pathology in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
The American journal of surgical pathology 1987;11(12):965-71.
-
1987: Messner H A; Curtis J E; Minden M D; Tritchler D; Lockwood G; Takahashi T; Lepine J; Jamal N; Tweeddale M; Wandl U
Clonogenic hemopoietic precursors in bone marrow transplantation.
Blood 1987;70(5):1425-32.
-
1987: Chan C K; Hyland R H; Hutcheon M A; Minden M D; Alexander M A; Kossakowska A E; Urbanski S J; Fyles G M; Fraser I M; Curtis J E
Small-airways disease in recipients of allogeneic bone marrow transplants. An analysis of 11 cases and a review of the literature.
Medicine 1987;66(5):327-40.
-
1987: Miyauchi J; Kelleher C A; Yang Y C; Wong G G; Clark S C; Minden M D; Minkin S; McCulloch E A
The effects of three recombinant growth factors, IL-3, GM-CSF, and G-CSF, on the blast cells of acute myeloblastic leukemia maintained in short-term suspension culture.
Blood 1987;70(3):657-63.
-
1987: Tweeddale M E; Lim B; Jamal N; Robinson J; Zalcberg J; Lockwood G; Minden M D; Messner H A
The presence of clonogenic cells in high-grade malignant lymphoma: a prognostic factor.
Blood 1987;69(5):1307-14.
-
1987: Kelleher C; Miyauchi J; Wong G; Clark S; Minden M D; McCulloch E A
Synergism between recombinant growth factors, GM-CSF and G-CSF, acting on the blast cells of acute myeloblastic leukemia.
Blood 1987;69(5):1498-503.
-
1987: Curtis J E; Messner H A; Minden M D; Minkin S; McCulloch E A
High-dose cytosine arabinoside in the treatment of acute myelogenous leukemia: contributions to outcome of clinical and laboratory attributes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(4):532-43.
-
1987: McCulloch E A; Minden M D; Kelleher C; Miyauchi J; Wang C; Cheng G Y
Genetically determined regulators acting on the blast cells of acute myeloblastic leukemia.
Acta haematologica 1987;78 Suppl 1():18-25.
-
1986: Griesser H; Feller A; Lennert K; Minden M; Mak T W
Rearrangement of the beta chain of the T cell antigen receptor and immunoglobulin genes in lymphoproliferative disorders.
The Journal of clinical investigation 1986;78(5):1179-84.
Sign-in to see more